These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Contribution to the knowledge of pervitin psychoses]. WALTHER R Psychiatr Neurol Med Psychol (Leipz); 1951 Jun; 3(6):165-71. PubMed ID: 14864746 [No Abstract] [Full Text] [Related]
10. 3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT. SHULGIN AT Nature; 1964 Mar; 201():1120-1. PubMed ID: 14152788 [No Abstract] [Full Text] [Related]
11. [Psychotic manifestations of pervitin abuse]. KALUS F Psychiatr Neurol Med Psychol (Leipz); 1950 Apr; 2(4):109-16. PubMed ID: 15424295 [No Abstract] [Full Text] [Related]
12. [Psychotic manifestations of chronic pervitin abuse]. KALUS F Psychiatr Neurol Med Psychol (Leipz); 1950 May; 2(5):138-44. PubMed ID: 15424300 [No Abstract] [Full Text] [Related]
13. A case of recurrent psychosis associated with amphetamine addiction. O'FLANAGAN PM; TAYLOR RB J Ment Sci; 1950 Oct; 96(405):1033-6. PubMed ID: 14804039 [No Abstract] [Full Text] [Related]
15. [Psychiatric syndromes following the use of amphetamines]. GRANTHAM H; MARTIN CA; ROULEAU Y Laval Med; 1962 Feb; 33():85-9. PubMed ID: 13901178 [No Abstract] [Full Text] [Related]
16. Clinical and biochemical studies of an amphetamine withdrawal psychosis. YOUNG GG; SIMSON CB; FROHMAN CE J Nerv Ment Dis; 1961 Mar; 132():234-8. PubMed ID: 13787461 [No Abstract] [Full Text] [Related]
17. [Dream-like episode after a therapeutic amphetamine injection]. AYACHE C Maroc Med; 1960 May; 39():555-6. PubMed ID: 13795334 [No Abstract] [Full Text] [Related]